BENCO DENTAL SUPPLY CO. 3846-368 IRIS

The Datex Ohmeda Aestiva/5 MRI is a specialized anesthesia machine designed for use in magnetic resonance imaging (MRI) environments. Last Preventative Maintenance Date: May 2024 Reports/Certificate of Inspection: Available upon request. Condition: The machine is in great condition. Notes: The cap for the APL valve is cracked. This defect does not impact the machine's functionality. Usage: Detailed cycle counts or precise usage statistics are not available. Reason for Sale: The equipment is no longer needed by the selling facility. Warranty Status: There is no current warranty. The warranty will not be valid upon transfer. Purchase Background: The item was purchased directly from the Original Equipment Manufacturer (OEM). Accessories: No additional accessories are being sold with this item.

The T1CMR Phantom contains a range of nickel chloride in agarose solutions that mimic cardiac T1 and T2 values. T1 measurement is used to calculate the extravascular volume fraction (ECV) to detect diffuse myocardial fibrosis. It is provided to MRI Centres for the verification of T1-mapping stability across different 3.0T scanners (different manufacturers and models) and to understand the feasibility of delivering a “T1 standard”.

Standalone software as medical device (SaMD) designed to automatically analyse within seconds magnetic resonance imaging (MRI) datasets to generate an estimate of the patient’s volumetric liver fat fraction (VLFF), converted into proton density fat fraction (PDFF) and steatosis grade. No user input is required for the analysis thus minimising the impact of human error on obtained results. HepaFatSmart is intended for the quantitative evaluation of volumetric liver fat fraction (VLFF), proton density fat fraction (PDFF) and liver steatosis grading.It utilises magnetic resonance images that exploit the difference in resonance frequencies between hydrogen nuclei in water and triglyceride fat. The quantitative triglyceride fat fraction is based on the measurement of a magnetic resonance parameter that reflects the ratio of the proton density signal of triglyceride fat to the total proton density signal in the liver.When interpreted by a trained physician, the results provide information that can aid in diagnosis.HepaFatSmart is indicated to:• Support clinical diagnoses in individuals with confirmed or suspected fatty liver disease; • Assessment of liver fat content to support the subsequent clinical decision-making processes for patients under management of diseases such as non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), viral hepatitis. • Support the subsequent clinical decision-making processes for patients Results, when interpreted by a trained physician can be used to support clinical diagnoses about the status of liver fat content, the subsequent clinical decision-making processes for the management of fatty liver related diseases.

Articulating Forcep

• 3 Ply - Disposable High Filtration Face Mask• Face Mask Size: 170mm x 90mm (± 5 mm) • Non - sterile, single use• Color White• 50 masks pack in one box• Box dimensions: 185x105x90mm

Virtual Field VF3 is a portable virtual reality visual field device. It runs a variety of visual field patterns, including but not limited to 10-2, 24-2, and 30-2, as well as multiple strategies, from suprathreshold screenings to full threshold tests. It also includes a color vision screening exam.

The Datex Ohmeda Aestiva/5 MRI is a specialized anesthesia machine designed for use in magnetic resonance imaging (MRI) environments. Last Preventative Maintenance Date: May 2024 Reports/Certificate of Inspection: Available upon request. Condition: The machine is in great condition. Notes: The cap for the APL valve is cracked. This defect does not impact the machine's functionality. Usage: Detailed cycle counts or precise usage statistics are not available. Reason for Sale: The equipment is no longer needed by the selling facility. Warranty Status: There is no current warranty. The warranty will not be valid upon transfer. Purchase Background: The item was purchased directly from the Original Equipment Manufacturer (OEM). Accessories: No additional accessories are being sold with this item.

The T1CMR Phantom contains a range of nickel chloride in agarose solutions that mimic cardiac T1 and T2 values. T1 measurement is used to calculate the extravascular volume fraction (ECV) to detect diffuse myocardial fibrosis. It is provided to MRI Centres for the verification of T1-mapping stability across different 3.0T scanners (different manufacturers and models) and to understand the feasibility of delivering a “T1 standard”.

Standalone software as medical device (SaMD) designed to automatically analyse within seconds magnetic resonance imaging (MRI) datasets to generate an estimate of the patient’s volumetric liver fat fraction (VLFF), converted into proton density fat fraction (PDFF) and steatosis grade. No user input is required for the analysis thus minimising the impact of human error on obtained results. HepaFatSmart is intended for the quantitative evaluation of volumetric liver fat fraction (VLFF), proton density fat fraction (PDFF) and liver steatosis grading.It utilises magnetic resonance images that exploit the difference in resonance frequencies between hydrogen nuclei in water and triglyceride fat. The quantitative triglyceride fat fraction is based on the measurement of a magnetic resonance parameter that reflects the ratio of the proton density signal of triglyceride fat to the total proton density signal in the liver.When interpreted by a trained physician, the results provide information that can aid in diagnosis.HepaFatSmart is indicated to:• Support clinical diagnoses in individuals with confirmed or suspected fatty liver disease; • Assessment of liver fat content to support the subsequent clinical decision-making processes for patients under management of diseases such as non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), viral hepatitis. • Support the subsequent clinical decision-making processes for patients Results, when interpreted by a trained physician can be used to support clinical diagnoses about the status of liver fat content, the subsequent clinical decision-making processes for the management of fatty liver related diseases.